NDRA
What one share of Endra Life Sciences holds
Electromedical and Electrotherapeutic Apparatus
We were incorporated as a Delaware corporation in 2007. We are developing a next-generation enhanced ultrasound technology platform—Thermo- Acoustic Enhanced
Endra Life Sciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$5.38 |
|---|---|
| Capex (buildings and equipment) | $0.02 |
| Free cash flow | −$4.40 |
| Cash and investments | $1.16 |
| Book value | $4.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2016 | $0.71 | −$3.84 | — | −$1.82 | — | −$1.24 |
| 2017 | $0.13 | −$1.95 | $0.00 | −$1.20 | — | $1.34 |
| 2018 | $0.00 | −$2.17 | $0.02 | −$1.73 | — | $0.84 |
| 2019 | $0.00 | −$2.34 | $0.01 | −$1.15 | — | $0.57 |
| 2020 | $0.00 | −$0.63 | $0.00 | −$0.56 | — | $0.21 |
| 2024 | — | −$56.94 | $0.08 | −$36.70 | — | — |
| 2025 | — | −$8.93 | $0.02 | −$6.61 | — | $1.92 |